Yu Mingde: Interpretation and Prospect of the development trend of the pharmaceutical industry

Yu Mingde: engaged in the management of drug production and circulation for a long time Now he is the honorary president of China Pharmaceutical Enterprise Management Association He once served as technician of Fuxin Chemical Research Institute, technical section chief and director of Fuxin pharmaceutical factory and traditional Chinese medicine factory, general manager of Pharmaceutical General Company and director of municipal pharmaceutical administration, deputy director and director of Liaoning Pharmaceutical Administration, director of Finance and market circulation department of State Pharmaceutical Administration, director of Pharmaceutical Department of State Economic and Trade Commission, deputy director of Economic Operation Bureau and national development and reform Deputy director of the economic operation Bureau of the Reform Commission Now, he is invited to concurrently serve as researcher of international pharmaceutical research center of Peking University, deputy director of biomedical Expert Advisory Committee of national development and Reform Commission, expert of drug circulation industry expert committee of Ministry of Commerce, expert of 13th five year plan of Ministry of industry and information technology, expert of 09 special evaluation group of Chinese Academy of engineering, and expert of national made in China 2025 Advisory Committee Yu Mingde, honorary president of China Pharmaceutical Enterprise Management Association, speech title: development situation, policies and suggestions of pharmaceutical industry theme Abstract: in the upcoming 2016 China Pharmaceutical R & D Innovation Summit, Yu Mingde, President of China Pharmaceutical Enterprise Management Association, interpreted the current situation, policies and suggestions in the development of pharmaceutical industry with a farsighted vision In terms of the current situation of China's pharmaceutical industry, president Yu has made a comprehensive plan for the relevant contents of the pharmaceutical industry, explained various subdivisions, and clarified the opportunities and challenges in the current pharmaceutical development In terms of policy, president Yu made a penetrating analysis of the policy environment, and made effective foresight on how to guide the current situation according to the circumstances In addition, more than 10 core topics, such as the reform of medical device review and approval, data verification, consistency evaluation, process verification, traditional Chinese medicine formula particle management, and drug Internet transaction, which are concerned by pharmaceutical enterprises at that time, have been disclosed in depth, and countermeasures have been put forward At present, the development of pharmaceutical enterprises is facing multiple puzzles and tests How to break out of the siege under the severe situation is the most concern of many pharmaceutical enterprises President Yu Mingde analyzes this one by one from international to domestic Internationally, how should pharmaceutical companies be internationalized and break through what key points to make breakthrough in key areas of the Internet environment? How can China's pharmaceutical industry achieve a qualitative leap in the international arena under the environment of Internet plus? How can we make use of existing resources in the domestic market, so that pharmaceutical enterprises can continuously pour into the fresh blood and increase endogenous motivation, and promote the development of pharmaceutical industry to usher in a new trend? What is it, and how to break it one by one, so as to promote its own R & D and innovation of new drugs and generic drugs to leapfrog several levels and connect with the international stage On September 24, 2016, president Yu Mingde will take his understanding of China's pharmaceutical industry for many years to the stage of 2016 China Pharmaceutical R & D Innovation Summit, share decades of exclusive experience for you, and strive to contribute to the development of the pharmaceutical industry In the pharmaceutical industry, Yu has been working hard for many years and has an absolute voice in this field If you are a pharmaceutical enterprise, Research Institute, scientific research personnel, etc., this feast is undoubtedly the best choice for you to break the high threshold of innovation and win the market.